Objective: To develop a kind of daunorubicin plus chloroquine liposomes for treating brain glioma and glioma stem cells,to characterize their physicochemical properties,and to observe their inhibitory effects on the brain glioma and glioma stem cells. Methods: In preparing the daunorubicin plus chloroquine liposomes,daunorubicin was loaded into the liposomes as the anticancer drug and chloroquine was incorporated as the drug-resistant regulating agent. The developed liposomes were characterized by evaluatin...